These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25757623)

  • 21. Anti-HIV inhibitors based on nucleic acids: emergence of aptamers as potent antivirals.
    Joshi PJ; Fisher TS; Prasad VR
    Curr Drug Targets Infect Disord; 2003 Dec; 3(4):383-400. PubMed ID: 14754437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene silencing of HIV-1 by RNA interference.
    Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):57-65. PubMed ID: 15185724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects.
    Kruspe S; Giangrande PH
    Biomedicines; 2017 Aug; 5(3):. PubMed ID: 28792479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
    McNamara JO; Andrechek ER; Wang Y; Viles KD; Rempel RE; Gilboa E; Sullenger BA; Giangrande PH
    Nat Biotechnol; 2006 Aug; 24(8):1005-15. PubMed ID: 16823371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection.
    Bivalkar-Mehla S; Mehla R; Chauhan A
    J Drug Target; 2017 Apr; 25(4):307-319. PubMed ID: 27800697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs.
    Khanali J; Azangou-Khyavy M; Asaadi Y; Jamalkhah M; Kiani J
    Front Microbiol; 2021; 12():758948. PubMed ID: 34858370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress towards therapeutic application of RNA interference for HIV infection.
    Singh SK; Gaur RK
    BioDrugs; 2009; 23(5):269-76. PubMed ID: 19754217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small RNAs to treat human immunodeficiency virus type 1 infection by gene therapy.
    Goguen RP; Malard CM; Scarborough RJ; Gatignol A
    Curr Opin Virol; 2019 Oct; 38():10-20. PubMed ID: 31112858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
    Kruspe S; Giangrande PH
    Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
    Bagalkot V; Gao X
    ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.
    Wheeler LA; Trifonova R; Vrbanac V; Basar E; McKernan S; Xu Z; Seung E; Deruaz M; Dudek T; Einarsson JI; Yang L; Allen TM; Luster AD; Tager AM; Dykxhoorn DM; Lieberman J
    J Clin Invest; 2011 Jun; 121(6):2401-12. PubMed ID: 21576818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aptamers in the Treatment of Bacterial Infections: Problems and Prospects].
    Zeninskaya NA; Kolesnikov AV; Ryabko AK; Shemyakin IG; Dyatlov IA; Kozyr AV
    Vestn Ross Akad Med Nauk; 2016; 71(5):350-8. PubMed ID: 29297663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNAi as a treatment for HIV-1 infection.
    Rossi JJ
    Biotechniques; 2006 Apr; Suppl():25-9. PubMed ID: 16629384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current progress on aptamer-targeted oligonucleotide therapeutics.
    Dassie JP; Giangrande PH
    Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection.
    Morris KV; Rossi JJ
    Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA interference and its therapeutic potential against HIV infection.
    Singh SK
    Expert Opin Biol Ther; 2008 Apr; 8(4):449-61. PubMed ID: 18352849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamers: current challenges and future prospects.
    Rozenblum GT; Lopez VG; Vitullo AD; Radrizzani M
    Expert Opin Drug Discov; 2016; 11(2):127-35. PubMed ID: 26630462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside.
    Zeller SJ; Kumar P
    Yale J Biol Med; 2011 Sep; 84(3):301-9. PubMed ID: 21966049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.